Business Context and Reporting Period
Company: Torchmark Corporation (filing as Torchmark; note: input metadata referenced "Globe Life Inc." but the document is for Torchmark, the parent holding company of Globe Life and other subsidiaries).
Reporting Period: Fiscal year ended December 31, 2008.
Business Overview: Torchmark is an insurance holding company operating primarily in the middle-income market. Its core segments are Life Insurance, Health Insurance (including Medicare Supplement and Part D), and Annuities. The company utilizes a mix of direct response, exclusive agency, and independent agency distribution channels.
Key Financial Metrics
| Metric | 2008 | 2007 |
|---|---|---|
| Total Revenue | $3,326.9 million | $3,486.7 million |
| Net Income | $452.3 million | $527.5 million |
| Diluted EPS | $5.11 | $5.50 |
| Premium Revenue (Life) | $1,616.8 million | $1,570.0 million |
| Premium Revenue (Health) | $1,127.1 million | $1,236.8 million |
| Net Investment Income | $671.5 million | $648.8 million |
| Realized Investment Gains (Losses) | ($107.5 million) | $2.7 million |
| Total Assets | $13,529.1 million | $15,241.4 million |
| Shareholders' Equity | $2,222.9 million | $3,324.6 million |
| Short-term Debt | $403.7 million | $202.1 million |
| Long-term Debt | $622.8 million | $721.7 million |
| Cash Flow from Operations | $730.6 million | $850.0 million |
Material Changes vs. Prior Period
- Net Income Decline: Net income decreased 14% ($75.3 million) to $452.3 million. The primary driver was a pre-tax realized investment loss of $107.5 million, largely due to writedowns of securities issued by Lehman Brothers and Washington Mutual.
- Health Segment Pressure: Health insurance premium revenue declined 9% to $1.13 billion, and underwriting margin fell 7% to $194.7 million. This was attributed to intense competition and a significant decline in the agent count at the United American Branch Office Agency.
- Life Segment Growth: Life insurance premium revenue grew 3% to $1.62 billion, and underwriting margin increased 4% to $431.8 million, driven by premium growth and favorable mortality experience.
- Equity Volatility: Shareholders' equity dropped significantly from $3.32 billion to $2.22 billion. This was primarily due to a $1.8 billion increase in net unrealized losses on fixed-maturity investments caused by market illiquidity and spread widening, rather than realized losses.
- Share Repurchases: The company repurchased 7.6 million shares for $427 million in 2008, reducing the share count and mitigating the per-share earnings decline.
Guidance, Outlook, and Risks
- Investment Portfolio: Management expects to hold impaired securities to maturity, anticipating recovery. However, future net investment income is expected to be reduced by approximately $7 million annually due to the writedowns of Lehman and Washington Mutual securities.
- Health Outlook: The company is shifting emphasis in the United American Branch Office to higher-margin life and health products to rebuild stability. Medicare Part D growth is not expected in the near future as most beneficiaries enrolled in 2006.
- Liquidity: Parent company liquidity is supported by dividends from subsidiaries ($404 million received in 2008) and a $600 million credit facility ($95 million available at year-end). The company intends to refinance $99.5 million of senior debt due in August 2009.
- Key Risks:
- Investment Risk: Exposure to credit risk in the financial sector (37% of fixed maturities) and interest rate risk.
- Regulatory Risk: Potential changes to the Medicare program could impact Supplement and Part D businesses.
- Competition: Intense price competition in Medicare Supplement and limited-benefit health markets.
- Legal: Ongoing exposure to punitive damage litigation, particularly in Alabama and Mississippi.
Investor Verification Checklist
- Investment Writedowns: Verify the extent of exposure to financial sector issuers (Lehman, Washington Mutual) and the company's assessment of "other-than-temporary" impairment criteria.
- Health Agent Turnover: Monitor the recovery of the United American Branch Office agent count and its impact on future health premium growth.
- Debt Refinancing: Confirm the successful refinancing of the $99.5 million senior debentures due in August 2009.
- Unrealized Losses: Assess the impact of the $1.8 billion in unrealized losses on fixed maturities on regulatory capital ratios and dividend-paying capacity.
- Legal Settlements: Review the status of the Vesta litigation settlement and the Roberts/Robertson class action settlements to ensure no further material liabilities exist.